HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: jmg.2007.051854v1 45/1/43    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lesage, S Search for Related Content PubMed PubMed Citation Articles by Lesage, S Pubmed/NCBI databases Gene GEO Profiles HomoloGene OMIM UniGene Genetics Home Reference Medline Plus Health Information Parkinson's Disease Patient Rights

Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls

¹ INSERM UMR S679, Paris, France
² AP-HP, Groupe Pitié-Salpêtrière, Fédération des Maladies du Système Nerveux, Paris, France
³ AP-HP, Groupe Pitié-Salpêtrière, Département de Génétique et Cytogénétique, Paris, France
⁴ Université Pierre et Marie Curie-Paris VI, UFR, Groupe Pitié-Salpêtrière, Paris, France
⁵ Service de Neurologie, Hôpital Du Haut-Lévêque, Pessac, France
⁶ Service de Neurologie, Hôpital Gabriel Montpied, Clermont-Ferrand, France

Correspondence to:
Dr A Brice, INSERM UMR 679, Hôpital de la Salpêtrière, 47, Boulevard de l’Hôpital, 75651 Paris cedex 13, France; brice{at}ccr.jussieu.fr]

ABSTRACT
Background: Mutations in the parkin gene cause autosomal recessive early-onset parkinsonism. The effect of single heterozygous mutations in parkin is still unclear. The aim of this study was to evaluate the frequency of exonic parkin variants in a case–control study.

Methods: The parkin gene was screened for both point mutations and exon rearrangements in 172 French patients with Parkinson disease (PD) and 170 controls from the same population. Patients with single parkin variants were also screened for PINK1, DJ-1 and LRRK2 exon 41 mutations.

Results: 10 exonic sequence variations were identified, including 3 known polymorphisms and 7 rare heterozygous variants, 2 of which were novel. There were significantly more rare heterozygous variants in patients (n = 10) with early-onset PD than in controls (n = 2). Screening of PINK1, DJ-1 and LRRK2 exon 41 in the 10 patients heterozygous for parkin failed to identify a second causative mutation.

Conclusion: These results suggest that single parkin mutations increase the risk of early-onset PD, but the possibility of a second parkin mutation cannot be excluded.